Agenus reported $543K in Cost of Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbvie ABBV:US $ 4021M 259M
Agenus AGEN:US $ 543K 338K
Amgen AMGN:US $ 1561M 157M
AstraZeneca AZN:LN 2279M 790M
Bristol Myers Squibb BMY:US $ 2471M 115M
ChemoCentryx CCXI:US 205K 97K
CSL CSL:AU $ 2.59B 393M
Dynavax Technologies DVAX:US $ 39.96M 34.05M
Eli Lilly And LLY:US $ 2072.1M 21.9M
Gilead Sciences GILD:US $ 1424M 1203M
GlaxoSmithKline GSK:LN 3645M 30M
Glaxosmithkline GSK:US $ 3645M 30M
Intrexon XON:US $ 17.1M 2.17M
Jiangsu Hengrui Me. 600276:CH CH 855.29M 157.94M
Johnson & Johnson JNJ:US $ 7598M 357M
Karyopharm Therapeutics KPTI:US $ 1.43M 684K
MacroGenics MGNX:US 48K 899K
Merck MRK:GR € 1987M 28M
Merk MRK:US $ 5334M 1507M
Novartis NOVN:VX SF 3755M 245M
Pfizer PFE:US $ 10010M 399M
Regeneron Pharmaceuticals REGN:US $ 404.9M 577.7M
Rigel Pharmaceuticals RIGL:US $ 0.12M 0.37M
Veracyte VCYT:US $ 23.71M 0.83M
YTE INCY:US $ 37.21M 1.36M